跳到正文
ECA GMP News·· 11 天前AI 评分72

香港药剂业及毒药管理局实施药品优良运销规范指南,2026年9月30日起新牌照申请须符合

Hong Kong Implements GDP Guide for Pharmaceutical Products

AI 导读

香港药剂业及毒药管理局于2026年9月30日正式实施《药品优良运销规范指南》及配套业界指引。指南以PIC/S的PE 011-1和PI 047-1为基础,第一部分涵盖药品、第二部分涵盖活性成分。自2026年9月30日起,新申请批发商牌照或制造商牌照须符合该指南;现有批发商牌照及相关制造商牌照持有人则在2028年9月30日或之后续牌时以牌照条件方式符合,形成两年准备期。

正文 · 原文

Following our earlier reports on the public consultation (April 2026) and the authority's additional information (July 2026), the Pharmacy and Poisons Board of Hong Kong has now introduced the Guide to Good Distribution Practice for Pharmaceutical Products ("GDP Guide") and the Guidance for Industry: Guide to Good Distribution Practice for Pharmaceutical Products ("Guidance for Industry"). The Board formally implemented both documents on 30 September 2026.The main aspects can be summarised as follows: Documents: The GDP Guide is based on the PIC/S Guide to Good Distribution Practice for Medicinal Products (PE 011-1) and the PIC/S Guidelines on the Principles of Good Distribution Practice of Active Substances (PI 047-1). It has two parts: Part I covers pharmaceutical products, and Part II covers active substances. The Guidance for Industry supports holders of a Wholesale Dealer Licence ("WDL") in applying the GDP Guide. New applications: From 30 September 2026, applicants for a new WDL or Manufacturer Licence ("ML") must comply with the GDP Guide as a licensing requirement. Existing licences: Existing WDL holders and relevant ML holders engaged in wholesale dealing must comply by way of a licensing condition upon licence renewal on or after 30 September 2028. This provides a two-year preparatory period.Further information, the English-language documents and other relevant information can be found on the authority's website under "Implementation of Good Distribution Practice (GDP) for Pharmaceutical Products".

来源:ECA GMP News · gmp-compliance.org